NCT Number: NCT06750042
Analysis of Motor Performance in Children with Duchene's Muscular Dystrophy
25 boys, ages ranging from 6 to 16 years, diagnosed with Duchene's muscular Dystrophy (DMD) will participated in the study. They will be selected from the Pediatric Rehabilitation Center of Deraya University's outpatient clinic in El-Minia district, Minia-Egypt. The outcome will be assessed motor performance will be assed by Bruininks-Oseretsky Test of Motor Proficiency Second Edition (BOT™-2) : balance, running speed and agility, bilateral coordination and strength and by Blue Cherry; Geratherm Respiratory. It is used to measure vital capacity (VC), forced expired volume in one second (FEV1), FEV1/FVC, FEV1/VC, and peak expiratory flow (PEF) to provide objective information for monitoring lung health.
Trial opening soon.
Get NotifiedKey information
Conditions
Age range
6 year–16 year
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- the diagnosis is Duchene's muscular Dystrophy only not other types,
- ambulated with or without assistance,
- oriented and endurance enough to understand orders to perform ventilation on the Blue Cherry; Geratherm Respiratory device.
Exclusion criteria
- any cognitive or neurological condition (other than Duchene's muscular Dystrophy),
- history of previous surgical operations that can affect pulmonary functions, and structural scoliosis
Treatment and study plan
Primary outcomes
-
motor performance
Time frame: measured for one time
motor performance will be assessed by Bruininks-Oseretsky Test of Motor Proficiency Second Edition (BOT™-2)
-
respiratory function
Time frame: measured for only one time
respiratory function by Blue Cherry; Geratherm Respiratory. It is used to measure respiratory function to provide objective information for monitoring lung health.
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Cairo University
Other
Registry information
Important dates
- Study start
- 2024
- Primary completion
- 2025
- Study completion
- 2025
- First posted
- Dec 27, 2024
- Registry last updated
- Dec 27, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.